Increased expression of chemokines in patients with Wegener's granulomatosis - Modulating effects of methylprednisolone in vitro

Clinical and Experimental Immunology

Volumn 140, Issue 2, 2005, Pages 376-383

  Torheim, E A ^a   Yndestad, A ^a   Bjerkeli, V ^a   Halvorsen, B ^a   Aukrust, Pål ^a,b   Froland S S ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chemokines; Corticosteroid; Wegener's granulomatosis

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; CORTICOSTEROID; INTERLEUKIN 8; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STAPHYLOCOCCUS ENTEROTOXIN B;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; MALE; MEDIATOR; NEUTROPHIL CHEMOTAXIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; WEGENER GRANULOMATOSIS;

ADULT; AGED; CELLS, CULTURED; CHEMOKINES; ENTEROTOXINS; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; WEGENER GRANULOMATOSIS;

EID: 17644398502     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02770.x     Document Type: Article

References (24)

1. Fauci A, Wolff S. Wegner's granulomatosis. Medicine 1973; 73:535-61.
2. Jennette JC, Falk RJ, Andrassy K. Nomenclature of systemic vasculitides: proposal of an International Consensus Conference. Arthritis Rheum 1994; 37:187-92.
3. Yi ES, Colby TV. Wegener's granulomatosis. Semin Diagn Pathol 2001; 18:34-46.
4. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001; 2:108-15.
5. Cockwell P, Chakravorty SJ, Girdlestone J, Savage CO. Fractalkine expression in human renal inflammation. J Pathol 2002; 196:85-90.
6. Tam FW, Sanders JS, George A et al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant 2004; 19:2761-8.
7. Coulomb-L'Hermine A, Capron F, Zou W et al. Expression of the chemokine RANTES in pulmonary Wegener's granulomatosis. Hum Pathol 2001; 32:320-6.
8. Ralston DR, Marsh CB, Lowe MP, Wewers MD. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest 1997; 100:1416-24.
9. Zhou Y, Huang D, Farver C, Hoffman GS. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis. J Rheumatol 2003; 30:1541-7.
10. Taekema-Roelvink ME, Kooten C, Kooij SV, Heemskerk E, Daha MR. Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1. J Am Soc Nephrol 2001; 12:932-40.
11. Leavitt RY, Fauci AS, Bloch DA. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33:1101-7.
12. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994; 87:671-8.
13. Yndestad A, Damås JK, Eiken HG et al. Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res 2002; 54:175-82.
14. Yndestad A, Holm AM, Müller F et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 2003; 60:141-6.
15. Cockwell P, Brooks CJ, Adu D, Savage CO. Interleukin-8: a pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int 1999; 55:852-63.
16. Cockwell P, Howie AJ, Adu D, Savage CO. In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int 1998; 54:827-36.
17. Mayet W, Schwarting A, Barreiros AP, Schlaak J, Neurath M. Anti-PR-3 antibodies induce endothelial IL-8 release. Eur J Clin Invest 1999; 29:973-9.
18. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res 2004; 95:858-66.
19. Chadda K, Annane D. The use of corticosteroids in severe sepsis and acute respiratory distress syndrome. The use of corticosteroids in severe sepsis and acute respiratory distress syndrome. Ann Med 2002; 34:582-9.
20. Frieri M. Corticosteroid effects on cytokines and chemokines. Allergy Asthma Proc 1999; 20:147-59.
21. Popa ER, Stegeman CA, Bos NA, Kallenberg CG, Tervaert JW. Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis. Clin Exp Immunol 2003; 132:496-504.
22. Schaaf MJ, Cidlowski JA. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 2002; 83:37-48.
23. Hauk PJ, Hamid QA, Chrousos GP, Leung DY. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 2000; 105:782-7.
24. Aukrust P, Lien E, Kristoffersen AK et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency - possible immunologic and clinical consequences. Blood 1996; 87:674-81.